Shirai Yuichiro 白井悠一郎

… Alternative Names

白井悠一郎シライユウイチロウ

SHIRAI Yuichiro 白井悠一郎

Less

Researcher Number	70528801
Other IDs	https://orcid.org/0000-0002-6864-8941
Affiliation (Current)	2025: 日本医科大学, 医学部, 講師
Affiliation (based on the past Project Information) *help	2019 – 2023: 日本医科大学, 医学部, 講師 2016 – 2018: 日本医科大学, 医学部, 助教 2013: 慶應義塾大学, 医学部, 助教 2011: 慶應義塾大学, 医学部, 共同研究員 2010: 慶應義塾大学, 医学部, 研究員(非常勤)
Review Section/Research Field	Principal Investigator Basic Section 54020:Connective tissue disease and allergy-related / Collagenous pathology/Allergology / 膠原病・アレルギー・感染症内科学
Keywords	Principal Investigator 強皮症 / 骨芽細胞 / 石灰沈着症 / 血管病変 / 線維化 / 内科 / 血管内皮前駆細胞 / 肺高血圧 / 膠原病 / 肺高血圧症 / 膠原病学

間葉系組織からの骨芽細胞分化に着目した強皮症石灰沈着症の機序解明と治療標的探索Principal Investigator
- Principal Investigator
  
  白井悠一郎
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54020:Connective tissue disease and allergy-related
- Research Institution
  Nippon Medical School
Molecular mechanism of calcinosis in systemic sclerosisPrincipal Investigator
- Principal Investigator
  
  Shirai Yuichiro
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 54020:Connective tissue disease and allergy-related
- Research Institution
  Nippon Medical School
Identification of the therapeutic target in the early phase of development of systemic sclerosis related organ involvementPrincipal Investigator
- Principal Investigator
  
  Shirai Yuichiro
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Collagenous pathology/Allergology
- Research Institution
  Nippon Medical School
全身性強皮症におけるpentraxin 3の意義に関する研究Principal Investigator
- Principal Investigator
  
  白井悠一郎
- Project Period (FY)
  2013
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Collagenous pathology/Allergology
- Research Institution
  Keio University
A role of endothelial precursor cells in pulmonary arterial hypertension associated with connective tissue diseasePrincipal Investigator
- Principal Investigator
  
  SHIRAI Yuichiro
- Project Period (FY)
  2010 – 2011
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  膠原病・アレルギー・感染症内科学
- Research Institution
  Keio University

All 2022 2021 2020 2018 2012 2010

All Journal Article Presentation Book

[Book] リウマチ病学テキスト2022
- Author(s)
  一般社団法人日本リウマチ学会生涯教育委員会（分担執筆　白井悠一郎）
- Total Pages
  608
- Publisher
  南江堂
- ISBN
  9784524231584
- Data Source
  KAKENHI-PROJECT-19K08921
[Journal Article] Clinical worsening following discontinuation of tocilizumab in diffuse cutaneous systemic sclerosis: a single-centre experience in Japan2022
- Author(s)
  Isomura Y, Shirai Y, Kuwana M
- Journal Title
  
  Rheumatology (Oxford)
  
  Volume: - Issue: 11 Pages: 4491-4496
- DOI
  10.1093/rheumatology/keac136
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08921, KAKENHI-PROJECT-20K08812
[Journal Article] Use of vonoprazan, a novel potassium-competitive acid blocker, for the treatment of proton pump inhibitor-refractory reflux esophagitis in patients with systemic sclerosis2022
- Author(s)
  Shirai Y, Kawami N, Iwakiri K, Kuwana M
- Journal Title
  
  J Scleroderma Relat Disord
  
  Volume: 7 Issue: 1 Pages: 57-61
- DOI
  10.1177/23971983211021747
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08921, KAKENHI-PROJECT-20K08812
[Journal Article] Clinical relevance of the serial measurement of Krebs von den Lungen-6 levels in patients with systemic sclerosis-associated interstitial lung disease2021
- Author(s)
  Shirai Y, Fukue R, Kaneko Y, Kuwana M
- Journal Title
  
  Diagnostics
  
  Volume: 11 Issue: 11 Pages: 2007-2007
- DOI
  10.3390/diagnostics11112007
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08921, KAKENHI-PROJECT-20K08812
[Journal Article] NEFA/nucleobindin-2 is a target autoantigen of the anti-Wa antibody and is associated with transfer RNA2012
- Author(s)
  Imura Y, Shirai Y, Nojima T, et al
- Journal Title
  
  Mod Rheumatol
- NAID
  10031027691
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22790942
[Journal Article] NEFA/nucleobindin-2 is a target autoantigen of the anti-Wa antibody and is associated with transfer RNA.2012
- Author(s)
  Imura Y , Shirai Y , Nojima T, Nakashima R, Yamagata H, Miyachi K, Yoshifuji H, Kawabata D, Ohmura K, Usui T, Fujii T, Mimori T
- Journal Title
  
  Mod Rheumatol
  
  Volume: 22(5) Issue: 5 Pages: 685-94
- DOI
  10.1007/s10165-011-0582-9
- NAID
  120005054563
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22390201, KAKENHI-PROJECT-22790942
[Presentation] CLINICAL WORSENING FOLLOWING TAPERING OR WITHDRAWAL OF TOCILIZUMAB IN PATIENTS WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS: A REAL-WORLD EXPERIENCE2022
- Author(s)
  Isomura Y, Shirai Y, Kuwana M
- Organizer
  7th Systemic Sclerosis World Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08921
[Presentation] 全身性強皮症(SSc)に伴う間質性肺疾患(ILD)の進行予測に血清KL-6の経時的変化は有用でない2021
- Author(s)
  白井悠一郎, 福栄亮介, 山崎宜興, 竹内勤, 桑名正隆
- Organizer
  第65回日本リウマチ学会総会
- Data Source
  KAKENHI-PROJECT-19K08921
[Presentation] EFFECTIVENESS AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC SCLEROSIS: A PROPENSITY SCORE CONTROL MATCHED OBSERVATIONAL STUDY OF THE EUSTAR COHORT.2021
- Author(s)
  Kuster S, Jordan S, Elhai MD, …Shirai Y, …. Distler O on behalf of EUSTAR
- Organizer
  Annual European Congress of Rheumatology 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08921
[Presentation] OUTCOMES OF DOSE-REDUCTION OR DISCONTINUATION OF TOCILIZUMAB IN PATIENTS WITH EARLY DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS.2021
- Author(s)
  Isomura Y, Yamasaki Y, Shirai Y, Kuwana M
- Organizer
  Annual European Congress of Rheumatology 2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08921
[Presentation] Clinical characteristics in patients with systemic sclerosis and symptomatic subcutaneous calcinosis2020
- Author(s)
  Yuichiro Shirai, Masataka Kuwana
- Organizer
  Systemic Sclerosis World Congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08921
[Presentation] Clinical characteristics of critical limb ischemia in systemic sclerosis2018
- Author(s)
  Yuichiro Shirai, Yuka Okazaki, Masataka Kuwana
- Organizer
  5th systemic sclerosis world congress
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K09909
[Presentation] Outcomes of intravenous epoprostenol in patients with pulmonary arterial hypertension associated with connective tissue disease2012
- Author(s)
  Shirai Y, Yasuoka H, Takeuchi T, Satoh T, Kuwana M
- Organizer
  2nd Systemic Sclerosis World Congress
- Place of Presentation
  Madrid, Spain
- Year and Date
  2012-02-03
- Data Source
  KAKENHI-PROJECT-22790942
[Presentation] Outcomes of intravenous epoprostenol in patients with pulmonary arterial hypertension associated with connective tissue disease2012
- Author(s)
  Yuichiro Shirai
- Organizer
  2nd Systemic Sclerosis World Congress
- Place of Presentation
  Spain
- Year and Date
  2012-02-04
- Data Source
  KAKENHI-PROJECT-22790942
[Presentation] 当院における膠原病関連肺動脈性肺高血圧(PAH-CTD)の臨床特徴2010
- Author(s)
  白井悠一郎
- Organizer
  第54回日本リウマチ学会総会
- Place of Presentation
  神戸
- Year and Date
  2010-04-24
- Data Source
  KAKENHI-PROJECT-22790942

1. USUI Takashi

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
2. OHMURA Koichiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
3. 三森経世

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
4. 野島崇樹

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
5. 藤井隆夫

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Shirai Yuichiro 白井 悠一郎

白井 悠一郎 シライ ユウイチロウ

SHIRAI Yuichiro 白井 悠一郎

Research Projects

Research Products

Co-Researchers

間葉系組織からの骨芽細胞分化に着目した強皮症石灰沈着症の機序解明と治療標的探索Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Molecular mechanism of calcinosis in systemic sclerosisPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Identification of the therapeutic target in the early phase of development of systemic sclerosis related organ involvementPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

全身性強皮症におけるpentraxin 3の意義に関する研究Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

A role of endothelial precursor cells in pulmonary arterial hypertension associated with connective tissue diseasePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] リウマチ病学テキスト2022

Author(s)

Total Pages

Publisher

ISBN

Data Source

[Journal Article] Clinical worsening following discontinuation of tocilizumab in diffuse cutaneous systemic sclerosis: a single-centre experience in Japan2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Use of vonoprazan, a novel potassium-competitive acid blocker, for the treatment of proton pump inhibitor-refractory reflux esophagitis in patients with systemic sclerosis2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Clinical relevance of the serial measurement of Krebs von den Lungen-6 levels in patients with systemic sclerosis-associated interstitial lung disease2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] NEFA/nucleobindin-2 is a target autoantigen of the anti-Wa antibody and is associated with transfer RNA2012

Author(s)

Journal Title

NAID

Data Source

[Journal Article] NEFA/nucleobindin-2 is a target autoantigen of the anti-Wa antibody and is associated with transfer RNA.2012

Author(s)

Journal Title

DOI

NAID

Data Source

[Presentation] CLINICAL WORSENING FOLLOWING TAPERING OR WITHDRAWAL OF TOCILIZUMAB IN PATIENTS WITH DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS: A REAL-WORLD EXPERIENCE2022

Author(s)

Organizer

Data Source

[Presentation] 全身性強皮症(SSc)に伴う間質性肺疾患(ILD)の進行予測に血清KL-6の経時的変化は有用でない2021

Author(s)

Organizer

Data Source

[Presentation] EFFECTIVENESS AND SAFETY OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC SCLEROSIS: A PROPENSITY SCORE CONTROL MATCHED OBSERVATIONAL STUDY OF THE EUSTAR COHORT.2021

Author(s)

Organizer

Data Source

Shirai Yuichiro 白井悠一郎

白井悠一郎シライユウイチロウ

SHIRAI Yuichiro 白井悠一郎